Report Overview

Rising prevalence of infectious diseases, growing private healthcare sector, rapid advancements in diagnostic technologies, and growing awareness about early diagnosis are expected to drive India Emerging Infectious Disease Diagnostics Market during the forecast period between 2024 and 2030.

India Emerging Infectious Disease Diagnostics Market – Industry Trends & Forecast Report, 2030

India Emerging Infectious Disease Diagnostics Market size was estimated at USD 368.89 million in 2023. During the forecast period between 2024 and 2030, India Emerging Infectious Disease Diagnostics Market size is projected to grow at a CAGR of 10.13% reaching a value of USD 719.27 million by 2030. Prominent drivers of the market include significant advancements and innovations in diagnostic methods, particularly with the adoption of next-generation sequencing and the rising demand for rapid testing, as seen during the COVID-19 pandemic. The market is transitioning from an emerging phase to a growth phase, fueled by new technologies and devices that offer faster, more efficient, and cost-effective solutions. These developments have positioned infectious disease diagnostics as a cornerstone in the evolution of modern biotechnology, clinical diagnostics, and pathogen research. Accurate and timely diagnosis, effective patient management, enhanced public health surveillance, and continuous research and development are key factors contributing to the market's growth and its crucial role in healthcare and public health.

Emerging Infectious Disease Diagnostics – Overview

Emerging Infectious Disease Diagnostics refers to the tools, tests, and technologies used to detect and identify pathogens responsible for newly identified or re-emerging infectious diseases. These diagnostics are crucial in identifying infectious agents rapidly and accurately, allowing for timely intervention, treatment, and control of diseases that may have significant public health implications. Emerging infectious diseases are typically those that have recently appeared within a population or those whose incidence or geographic range is rapidly increasing or threatens to increase in the coming years. Diagnostic tools in this field often involve advanced techniques such as molecular diagnostics, next-generation sequencing, and rapid point-of-care tests, which are essential for managing outbreaks and mitigating the spread of these diseases.

India Emerging Infectious Disease Diagnostics Market

Growth Drivers

Rapid Advancements in Diagnostic Technologies

Rapid advancements in diagnostic technologies are significantly propelling the India Emerging Infectious Disease Diagnostics Market. The Indian government, through agencies like the Department of Biotechnology (DBT) and the Indian Council of Medical Research (ICMR), is fervently supporting research initiatives aimed at developing innovative diagnostic tools. These initiatives foster groundbreaking advancements that enhance the accuracy, speed, and efficiency of diagnostics for emerging infectious diseases. The continuous investment in research and development is driving the evolution of diagnostic technologies, enabling healthcare providers to implement swift and precise interventions, thereby improving public health outcomes.

Rising Awareness about Early Diagnosis

Rising awareness about the importance of early diagnosis is playing a crucial role in boosting the India Emerging Infectious Disease Diagnostics Market. In India, there is a growing recognition of the critical importance of detecting infectious diseases early to ensure effective disease management and curb transmission. Government initiatives, such as the Ayushman Bharat scheme, are instrumental in promoting preventive care and establishing health and wellness centers nationwide, which contribute to early disease detection. This heightened awareness is driving the demand for advanced diagnostic tools that can deliver quick and accurate results, emphasizing the vital role of early diagnosis in improving health outcomes.

Challenges

Limited Healthcare Infrastructure

Limited healthcare infrastructure significantly restrains the growth of the India Emerging Infectious Disease Diagnostics Market. Across regions, inadequate healthcare facilities, a shortage of trained medical professionals, and insufficient access to advanced diagnostic tools hinder the effective management and diagnosis of infectious diseases. Rural and underserved areas are particularly affected, where the lack of modern healthcare infrastructure limits the reach and impact of emerging diagnostic technologies. This gap in infrastructure not only slows the adoption of innovative diagnostics but also exacerbates the challenges in addressing the rising prevalence of infectious diseases across the country.

Impact of Escalating Geopolitical Tensions on India Emerging Infectious Disease Diagnostics Market

Escalating geopolitical tensions among countries across regions could have a significant impact on the growth of India Emerging Infectious Disease Diagnostics Market. These tensions can disrupt global supply chains, leading to shortages of critical diagnostic equipment and materials. Additionally, strained international relations may hinder collaborative research efforts and limit access to advanced technologies from other countries. Geopolitical instability can also divert government focus and resources away from healthcare initiatives, further exacerbating challenges in managing infectious diseases. The combined effect of these factors could slow the development and deployment of innovative diagnostic tools, restraining the market's growth in India.

India Emerging Infectious Disease Diagnostics Market

Segmental Coverage

India Emerging Infectious Disease Diagnostics Market – By Technology

By technology, India Emerging Infectious Disease Diagnostics Market is divided into Polymerase Chain Reaction (PCR), Isothermal Nucleic Acid Amplification Technology (INAAT), Next-Generation Sequencing (NGS), and Immunodiagnostics segments. The PCR segment holds the highest share in India Emerging Infectious Disease Diagnostics Market by technology, due to its unparalleled accuracy, sensitivity, and rapid detection capabilities. PCR technology is widely regarded as the gold standard for diagnosing infectious diseases, allowing for the precise identification of pathogens at the molecular level. Its ability to detect even minute quantities of viral or bacterial DNA makes it invaluable in early diagnosis and disease management. Moreover, the increasing prevalence of infectious diseases in India, coupled with the growing demand for reliable diagnostic tools, has further solidified PCR's dominance in the market. The technology's ongoing advancements and widespread adoption continue to drive its leading position in the industry.

India Emerging Infectious Disease Diagnostics Market – By Type of Infections

Based on type of infections, India Emerging Infectious Disease Diagnostics Market is divided into Bacterial, Viral, and Fungal segments. The bacterial segment holds the highest share in India Emerging Infectious Disease Diagnostics Market by type of infections. India's high population density, coupled with inadequate sanitation and hygiene practices, creates a fertile environment for the spread of bacterial diseases. The tropical climate in many regions further exacerbates this issue, making bacterial infections more prevalent. Rapid urbanization has led to overcrowded cities, where infectious diseases like tuberculosis, typhoid, and cholera can easily spread. Compounding these challenges, antibiotic resistance has become a significant concern due to the misuse and overuse of antibiotics, resulting in drug-resistant bacterial strains. Consequently, there is a growing need for advanced diagnostic tests to accurately identify the bacteria involved and determine the most effective treatment options.

India Emerging Infectious Disease Diagnostics Market – By Disease Type

By disease type, India Emerging Infectious Disease Diagnostics Market is divided into Respiratory Infections, Sexually Transmitted Infections (STIs), and Gastrointestinal Infections segments.

India Emerging Infectious Disease Diagnostics Market – By Application

Based on application, India Emerging Infectious Disease Diagnostics Market is bifurcated into Laboratory Testing and Point-of-Care Testing segments. The laboratory testing segment holds a higher share in India Emerging Infectious Disease Diagnostics Market by application, due to its superior accuracy, comprehensive analysis, and ability to handle a high volume of tests. Laboratory-based diagnostics are essential for detecting a wide range of infectious diseases, offering in-depth analysis that point-of-care tests may not provide. These tests are conducted in well-equipped facilities by trained professionals, ensuring precision in diagnosing complex infections. Additionally, laboratories can process large numbers of samples, making them critical in managing outbreaks and conducting surveillance. The reliability and thoroughness of laboratory testing have established its dominance in the market.

India Emerging Infectious Disease Diagnostics Market – By End User

Based on end user, India Emerging Infectious Disease Diagnostics Market is bifurcated into Hospitals & Clinics and Diagnostic Laboratories segments. The hospitals & clinics segment holds a higher share in India Emerging Infectious Disease Diagnostics Market by end user. Hospitals and clinics are pivotal in infectious disease diagnostics, serving as key locations for patient evaluation and testing. They utilize point-of-care testing (PoCT) for quick results and immediate management, but also depend on laboratory testing for more thorough analysis. Some healthcare facilities have advanced on-site laboratories, while others partner with external labs for specialized tests. These laboratories use a range of methods, including molecular techniques like PCR and sequencing, serological assays, and culture-based approaches, to accurately identify and characterize infectious agents. This combination of immediate and in-depth testing ensures effective diagnosis and treatment of infections.

India Emerging Infectious Disease Diagnostics Market – By Region

The in-depth research report on India Emerging Infectious Disease Diagnostics Market covers the market in the country’s major regions: North India, South India, East India, and West India regions. West India holds the highest share in India Emerging Infectious Disease Diagnostics Market and is expected to maintain its dominance during the forecast period. West India region, which includes major urban centers such as Mumbai and Pune, benefits from its high population density, creating a significant demand for diagnostic services. The dense population heightens the risk of rapid disease transmission, leading to a strong need for advanced diagnostic capabilities. West India's well-established healthcare infrastructure, including numerous hospitals, diagnostic centers, and research institutions, supports its market leadership by ensuring comprehensive and high-quality diagnostic services. Additionally, the presence of prestigious research institutions in the region drives innovation in diagnostic technologies, further solidifying West India's position as a key player in the diagnostics market. The interplay between these advanced research facilities and the robust healthcare system fosters an environment conducive to the growth and development of diagnostic solutions, reinforcing West India's dominant market share.

Competitive Landscape

Major players operating in India Emerging Infectious Disease Diagnostics Market include Abbott Laboratories, Becton Dickinson and Company, bioMérieux SA, Bio-Rad Laboratories Inc, DANAHER CORPORATION, DiaSorin SpA, Hoffmann-La Roche Ltd, QIAGEN NV, Thermo Fisher Scientific Inc, and Siemens Healthineers AG. To further enhance their market share, these companies employ various strategies, including mergers and acquisitions, partnerships, joint ventures, license agreements, and new product launches.

Recent Developments

• In October 2023 - Deenanath Mangeshkar Hospital recently inaugurated the 'Direct Relief Centre of Excellence in Infectious Diseases.' Established in collaboration with the US-based non-profit Direct Relief, the center is dedicated to providing high-quality diagnostic and therapeutic care for infectious diseases, accessible to all social and economic groups. It will also focus on research and training, offering academic programs such as fellowships and workshops.

• In February 2023 - Thermo Fisher Scientific Inc. and biotech leader Mylab formed a strategic partnership to develop advanced test kits for infectious diseases. The collaboration combines Thermo Fisher's molecular diagnostics expertise with Mylab's innovative technology, aiming to meet the increasing demand for accurate and efficient testing solutions.

Scope of the Report

By Technology

• Polymerase Chain Reaction (PCR)

• Isothermal Nucleic Acid Amplification Technology (INAAT)

• Next-Generation Sequencing (NGS)

• Immunodiagnostics

By Type of Infections

• Bacterial

• Viral

• Fungal

By Disease Type

• Respiratory Infections

• Sexually Transmitted Infections (STIs)

• Gastrointestinal Infections

By Application

• Laboratory Testing

• Point-of-Care Testing

By End User

• Hospitals & Clinics

• Diagnostic Laboratories

By Region

• North India

• South India

• East India

• West India